Logo image of NHTC

NATURAL HEALTH TRENDS CORP (NHTC) Stock Fundamental Analysis

NASDAQ:NHTC - Nasdaq - US63888P4063 - Common Stock - Currency: USD

4.72  -0.11 (-2.28%)

Fundamental Rating

3

Overall NHTC gets a fundamental rating of 3 out of 10. We evaluated NHTC against 35 industry peers in the Personal Care Products industry. While NHTC has a great health rating, there are worries on its profitability. NHTC does not seem to be growing, but still is valued expensively. Finally NHTC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year NHTC was profitable.
In the past year NHTC has reported a negative cash flow from operations.
In the past 5 years NHTC has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: NHTC reported negative operating cash flow in multiple years.
NHTC Yearly Net Income VS EBIT VS OCF VS FCFNHTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

NHTC has a Return On Assets of 0.95%. This is comparable to the rest of the industry: NHTC outperforms 57.14% of its industry peers.
NHTC has a better Return On Equity (1.64%) than 65.71% of its industry peers.
Industry RankSector Rank
ROA 0.95%
ROE 1.64%
ROIC N/A
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
NHTC Yearly ROA, ROE, ROICNHTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

Looking at the Profit Margin, with a value of 1.18%, NHTC is in line with its industry, outperforming 54.29% of the companies in the same industry.
In the last couple of years the Profit Margin of NHTC has declined.
NHTC has a Gross Margin of 74.04%. This is amongst the best in the industry. NHTC outperforms 85.71% of its industry peers.
NHTC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.18%
GM 74.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
NHTC Yearly Profit, Operating, Gross MarginsNHTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NHTC has about the same amount of shares outstanding.
Compared to 5 years ago, NHTC has more shares outstanding
NHTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NHTC Yearly Shares OutstandingNHTC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NHTC Yearly Total Debt VS Total AssetsNHTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

NHTC has an Altman-Z score of 2.10. This is not the best score and indicates that NHTC is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NHTC (2.10) is comparable to the rest of the industry.
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.1
ROIC/WACCN/A
WACC9.85%
NHTC Yearly LT Debt VS Equity VS FCFNHTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

NHTC has a Current Ratio of 2.35. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NHTC (2.35) is better than 62.86% of its industry peers.
NHTC has a Quick Ratio of 2.22. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.22, NHTC is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.22
NHTC Yearly Current Assets VS Current LiabilitesNHTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

NHTC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Measured over the past years, NHTC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.90% on average per year.
The Revenue has decreased by -0.63% in the past year.
Measured over the past years, NHTC shows a very negative growth in Revenue. The Revenue has been decreasing by -11.15% on average per year.
EPS 1Y (TTM)0%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-1.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHTC Yearly Revenue VS EstimatesNHTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
NHTC Yearly EPS VS EstimatesNHTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 0.01 0.02 0.03 0.04 0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 94.40, the valuation of NHTC can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of NHTC is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.52, NHTC is valued quite expensively.
Industry RankSector Rank
PE 94.4
Fwd PE N/A
NHTC Price Earnings VS Forward Price EarningsNHTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NHTC Per share dataNHTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 16.43%, NHTC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.56, NHTC pays a better dividend. On top of this NHTC pays more dividend than 100.00% of the companies listed in the same industry.
NHTC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 16.43%

5.2 History

The dividend of NHTC has a limited annual growth rate of 4.44%.
NHTC has paid a dividend for at least 10 years, which is a reliable track record.
NHTC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years10
NHTC Yearly Dividends per shareNHTC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

1820.75% of the earnings are spent on dividend by NHTC. This is not a sustainable payout ratio.
DP1820.75%
EPS Next 2YN/A
EPS Next 3YN/A
NHTC Yearly Income VS Free CF VS DividendNHTC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
NHTC Dividend Payout.NHTC Dividend Payout, showing the Payout Ratio.NHTC Dividend Payout.PayoutRetained Earnings

More info and screens

NATURAL HEALTH TRENDS CORP

NASDAQ:NHTC (6/6/2025, 8:13:34 PM)

4.72

-0.11 (-2.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-29 2025-07-29
Inst Owners10.09%
Inst Owner Change-4.52%
Ins Owners15.6%
Ins Owner Change0%
Market Cap54.33M
Analysts0
Price TargetN/A
Short Float %0.47%
Short Ratio1.29
Dividend
Industry RankSector Rank
Dividend Yield 16.43%
Yearly Dividend0.8
Dividend Growth(5Y)4.44%
DP1820.75%
Div Incr Years0
Div Non Decr Years10
Ex-Date05-13 2025-05-13 (0.2)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 94.4
Fwd PE N/A
P/S 1.27
P/FCF N/A
P/OCF N/A
P/B 1.76
P/tB 1.76
EV/EBITDA N/A
EPS(TTM)0.05
EY1.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS3.71
BVpS2.68
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.95%
ROE 1.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.18%
GM 74.04%
FCFM N/A
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.21%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.22
Altman-Z 2.1
F-Score4
WACC9.85%
ROIC/WACCN/A
Cap/Depr(3y)47.19%
Cap/Depr(5y)53.89%
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-1.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.25%
OCF growth 3YN/A
OCF growth 5YN/A